These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 22148963

  • 1. Emerging oral drugs for relapsing-remitting multiple sclerosis.
    Gasperini C, Ruggieri S.
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):697-712. PubMed ID: 22148963
    [Abstract] [Full Text] [Related]

  • 2. Emerging oral therapies for multiple sclerosis.
    Cohen BA, Rieckmann P.
    Int J Clin Pract; 2007 Nov; 61(11):1922-30. PubMed ID: 17784852
    [Abstract] [Full Text] [Related]

  • 3. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
    Sørensen PS.
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763
    [Abstract] [Full Text] [Related]

  • 4. An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
    Weinstock-Guttman B.
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635
    [Abstract] [Full Text] [Related]

  • 5. Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis.
    Comi G, Hartung HP, Kurukulasuriya NC, Greenberg SJ, Scaramozza M.
    Expert Opin Pharmacother; 2013 Jan; 14(1):123-36. PubMed ID: 23256518
    [Abstract] [Full Text] [Related]

  • 6. New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis.
    Fox EJ, Rhoades RW.
    Curr Opin Neurol; 2012 Feb; 25 Suppl():S11-9. PubMed ID: 22398660
    [Abstract] [Full Text] [Related]

  • 7. New oral drugs for multiple sclerosis.
    Gasperini C, Ruggieri S.
    Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drugs in development for relapsing multiple sclerosis.
    Ali R, Nicholas RS, Muraro PA.
    Drugs; 2013 May; 73(7):625-50. PubMed ID: 23609782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emerging oral agents for multiple sclerosis.
    Fox EJ.
    Am J Manag Care; 2010 Sep; 16(8 Suppl):S219-26. PubMed ID: 20873946
    [Abstract] [Full Text] [Related]

  • 13. Advances in the treatment of relapsing-remitting multiple sclerosis.
    Tanasescu R, Ionete C, Chou IJ, Constantinescu CS.
    Biomed J; 2014 Sep; 37(2):41-9. PubMed ID: 24732658
    [Abstract] [Full Text] [Related]

  • 14. Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis.
    Thöne J, Gold R.
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):365-70. PubMed ID: 21306281
    [Abstract] [Full Text] [Related]

  • 15. New and emerging disease modifying therapies for multiple sclerosis.
    Saidha S, Eckstein C, Calabresi PA.
    Ann N Y Acad Sci; 2012 Jan; 1247():117-37. PubMed ID: 22224673
    [Abstract] [Full Text] [Related]

  • 16. Fingolimod for relapsing multiple sclerosis: an update.
    Horga A, Castilló J, Montalban X.
    Expert Opin Pharmacother; 2010 May; 11(7):1183-96. PubMed ID: 20367536
    [Abstract] [Full Text] [Related]

  • 17. Dimethyl fumarate for multiple sclerosis.
    Papadopoulou A, D'Souza M, Kappos L, Yaldizli O.
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1603-12. PubMed ID: 21067468
    [Abstract] [Full Text] [Related]

  • 18. Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis.
    Oh J, O'Connor PW.
    CNS Drugs; 2013 Aug; 27(8):591-609. PubMed ID: 23801528
    [Abstract] [Full Text] [Related]

  • 19. Laquinimod, a new oral autoimmune modulator for the treatment of relapsing-remitting multiple sclerosis.
    Tselis A.
    Curr Opin Investig Drugs; 2010 May; 11(5):577-85. PubMed ID: 20419604
    [Abstract] [Full Text] [Related]

  • 20. Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.
    Papadopoulou A, Kappos L, Sprenger T.
    Expert Opin Drug Saf; 2015 May; 14(5):749-59. PubMed ID: 25687236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.